{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:00:50Z","timestamp":1794607250448,"version":"4.9.1"},"reference-count":145,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"crossref","award":["11M2324N"],"award-info":[{"award-number":["11M2324N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds UGent","doi-asserted-by":"crossref","award":["BOF22\/DOC\/302"],"award-info":[{"award-number":["BOF22\/DOC\/302"]}],"id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds UGent","doi-asserted-by":"crossref","award":["01D05220"],"award-info":[{"award-number":["01D05220"]}],"id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Capillary blood microsampling enables the sampling of small blood volumes, making it suitable for vulnerable populations, remote collection, and repeated sampling. Owing to its minimal invasiveness, blood microsampling has emerged as an alternative to venipuncture in many fields. However, as capillary blood differs from venous blood in composition and analytes vary in their distribution between the blood cell and plasma fractions, plasma and capillary blood concentrations may differ. Because plasma is often the standard matrix for routine analyses, this discrepancy can compromise the clinicians' interpretation of capillary blood results. Hence, to ensure comparability with results obtained through plasma-based assays and reference ranges, accurate conversion to plasma concentrations may be required, which may improve the reliability and validity of microsampling-based outcomes. Despite its relevance, guidance on whether conversion is appropriate or desired and on how to translate and validate the translation of capillary blood microsampling results to plasma concentrations is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>To address this gap, members of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) expert committees have prepared this guideline to discuss the \u201cwhat, when, and how\u201d of converting capillary to plasma concentrations and provide guidance on the decision of fit-for-purpose conversion. In addition, guidance to assess capillary blood results when the reference matrix is whole blood and to assess liquid capillary plasma results is provided. The included topics, as well as considerations and recommendations presented in this guideline, were based on a previously published dried blood spot-based IATDMCT guideline, literature review and expert opinions of the authors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and conclusions:<\/jats:title>\n                    <jats:p>Key points include the importance of conducting a comprehensive clinical validation study to fully understand capillary blood microsampling results. In addition, the performance of the conversion method should be evaluated case by case, as it depends on both the microsampling-based method and analyte of interest. Furthermore, an independent set of paired capillary and venous samples should be used to validate an established conversion formula. Finally, a key point for future studies is to focus on the clinical impact of (converted) capillary blood concentrations in comparison with decisions based on results in the reference matrix to guarantee any microsampling-based outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001393","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:00:36Z","timestamp":1762376436000},"page":"1-26","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["To Convert or Not to Convert? Official International Association of Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Considerations and Recommendations for Converting Capillary Blood Microsampling Concentrations to Plasma Concentrations"],"prefix":"10.1097","volume":"48","author":[{"given":"Laura","family":"Boffel","sequence":"first","affiliation":[{"name":"Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"De Baets","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesl","family":"Heughebaert","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Rispens","sequence":"additional","affiliation":[{"name":"Sanquin Research, Amsterdam, the Netherlands;"},{"name":"Amsterdam UMC Location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, Amsterdam, the Netherlands;"},{"name":"Amsterdam Institute for Immunology and Infectious Diseases, Immunology, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00c5sberg","sequence":"additional","affiliation":[{"name":"Department of Transplantation Medicine, University Hospital\u2014Rikshospitalet, Oslo, Norway;"},{"name":"Department of Pharmacy, University of Oslo, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Shipkova","sequence":"additional","affiliation":[{"name":"Bioscientia Institute for Medical Diagnostics GmbH, Ingelheim am Rhein, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda C. M.","family":"de Winter","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk Jan A. R.","family":"Moes","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"de Vries","sequence":"additional","affiliation":[{"name":"Sanquin Diagnostic Services, Amsterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[{"name":"Westmead Hospital, Department of Pharmacy, Sydney, NSW, Australia; and"},{"name":"School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-348X","authenticated-orcid":false,"given":"Christophe P.","family":"Stove","sequence":"additional","affiliation":[{"name":"Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"R1-20260108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: development and validation of dried blood spot-based methods for Therapeutic Drug Monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther Drug Monit"},{"key":"R2-20260108","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FTD.0000000000000864","article-title":"Alternative sampling devices to collect dried blood microsamples: state-of-the-art","volume":"43","author":"Delahaye","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R3-20260108","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ansa.202300011","article-title":"Blood microsampling technologies: innovations and applications in 2022","volume":"4","author":"Thangavelu","year":"2023","journal-title":"Anal Sci Adv"},{"key":"R4-20260108","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"R5-20260108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpba.2016.06.026","article-title":"Clinical feasibility of dried blood spots: analytics, validation, and applications","volume":"130","author":"Enderle","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"R6-20260108","doi-asserted-by":"crossref","first-page":"e1733","DOI":"10.1097\/TXD.0000000000001733","article-title":"Patiromer does not alter tacrolimus pharmacokinetics in kidney transplant recipients when administered three hours post-tacrolimus","volume":"10","author":"Drevland","year":"2024","journal-title":"Transpl Direct"},{"key":"R7-20260108","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1111\/bcp.14842","article-title":"Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients","volume":"87","author":"Martial","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"R8-20260108","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the International Association of Therapeutic Drug Monitoring and clinical toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R9-20260108","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4155\/bio.10.159","article-title":"Pharmacokinetic considerations as to when to use dried blood spot sampling","volume":"2","author":"Emmons","year":"2010","journal-title":"Bioanalysis"},{"key":"R10-20260108","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00007691-200010000-00015","article-title":"Accuracy of cyclosporin measurements made in capillary blood samples obtained by skin puncture","volume":"22","author":"Merton","year":"2000","journal-title":"Ther Drug Monit"},{"key":"R11-20260108","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1208\/s12248-010-9188-y","article-title":"Use of dried blood spots in drug development: pharmacokinetic considerations","volume":"12","author":"Rowland","year":"2010","journal-title":"AAPS J"},{"key":"R12-20260108","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00003088-198917030-00004","article-title":"The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I)","volume":"17","author":"Chiou","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"R13-20260108","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinbiochem.2010.06.014","article-title":"The analysis of dried blood spot samples using liquid chromatography tandem mass spectrometry","volume":"44","author":"Keevil","year":"2011","journal-title":"Clin Biochem"},{"key":"R15-20260108","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11095-021-03036-6","article-title":"Dried blood spot technique applied in therapeutic drug monitoring of anticancer drugs: a review on conversion methods to correlate plasma and dried blood spot concentrations","volume":"38","author":"Iacuzzi","year":"2021","journal-title":"Pharm Res"},{"key":"R16-20260108","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/FTD.0000000000000890","article-title":"Therapeutic drug monitoring of lamotrigine, lacosamide, and levetiracetam in dried capillary blood-determination of conversion factors for serum-based reference ranges","volume":"43","author":"Klimpel","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R17-20260108","doi-asserted-by":"crossref","first-page":"821807","DOI":"10.3389\/fonc.2022.821807","article-title":"Therapeutic drug monitoring of tyrosine kinase inhibitors using dried blood microsamples","volume":"12","author":"Verougstraete","year":"2022","journal-title":"Front Oncol"},{"key":"R18-20260108","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/FTD.0000000000001056","article-title":"Validation of conversion factors for therapeutic drug monitoring of lacosamide, lamotrigine, and levetiracetam in dried capillary blood","volume":"45","author":"Hagemann","year":"2023","journal-title":"Ther Drug Monit"},{"key":"R19-20260108","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s43440-023-00509-w","article-title":"Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application","volume":"75","author":"Kocur","year":"2023","journal-title":"Pharmacol Rep"},{"key":"R20-20260108","doi-asserted-by":"crossref","first-page":"115311","DOI":"10.1016\/j.jpba.2023.115311","article-title":"Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinib","volume":"228","author":"Zimmermann","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"R21-20260108","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4093\/dmj.2016.40.5.365","article-title":"Blood glucose measurement: is serum equal to plasma?","volume":"40","author":"Kim","year":"2016","journal-title":"Diabetes Metab J"},{"key":"R22-20260108","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ejhf.1371","article-title":"Clinical and research implications of serum versus plasma potassium measurements","volume":"21","author":"Cooper","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"R24-20260108","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/clinchem\/45.6.882","article-title":"Necessary sample size for method comparison studies based on regression analysis","volume":"45","author":"Linnet","year":"1999","journal-title":"Clin Chem"},{"key":"R25-20260108","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/TP.0000000000001591","article-title":"Clinical validation of simultaneous analysis of tacrolimus, cyclosporine A, and creatinine in dried blood spots in kidney transplant patients","volume":"101","author":"Veenhof","year":"2017","journal-title":"Transplantation"},{"key":"R26-20260108","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1111\/bcp.15870","article-title":"Clinical performance of volumetric finger-prick sampling for the monitoring of tacrolimus, creatinine and haemoglobin in kidney transplant recipients","volume":"89","author":"Vethe","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"R28-20260108","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2125.2010.03668.x","article-title":"Can finger-prick sampling replace venous sampling to determine the pharmacokinetic profile of oral paracetamol?","volume":"70","author":"Mohammed","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"R29-20260108","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4155\/bio.13.156","article-title":"Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions","volume":"5","author":"De Kesel","year":"2013","journal-title":"Bioanalysis"},{"key":"R30-20260108","doi-asserted-by":"crossref","first-page":"122623","DOI":"10.1016\/j.jchromb.2021.122623","article-title":"Volumetric absorptive microsampling as alternative sampling technique for renal function assessment in the paediatric population using iohexol","volume":"1171","author":"Dhondt","year":"2021","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R31-20260108","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.ki.5000240","article-title":"Development of an outpatient finger-prick glomerular filtration rate procedure suitable for epidemiological studies","volume":"69","author":"Niculescu-Duvaz","year":"2006","journal-title":"Kidney Int"},{"key":"R32-20260108","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/bcp.15433","article-title":"Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients","volume":"88","author":"Zwart","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"R33-20260108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cca.2018.02.024","article-title":"Quantitation of 25-hydroxyvitamin D in dried blood spots by 2D LC-MS\/MS without derivatization and correlation with serum in adult and pediatric studies","volume":"481","author":"Jensen","year":"2018","journal-title":"Clin Chim Acta"},{"key":"R34-20260108","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1542\/peds.2008-2654","article-title":"Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system","volume":"123","author":"Jopling","year":"2009","journal-title":"Pediatrics"},{"key":"R35-20260108","doi-asserted-by":"crossref","first-page":"341964","DOI":"10.1016\/j.aca.2023.341964","article-title":"Rapid LC-MS\/MS detection of 25-hydroxyvitamin D in dried blood spots","volume":"1283","author":"Wang","year":"2023","journal-title":"Anal Chim Acta"},{"key":"R36-20260108","doi-asserted-by":"crossref","first-page":"19873","DOI":"10.1038\/s41598-020-76955-w","article-title":"A LC-MS method for 25-hydroxy-vitamin D3 measurements from dried blood spots for an epidemiological survey in India","volume":"10","author":"Lote-Oke","year":"2020","journal-title":"Sci Rep"},{"key":"R37-20260108","doi-asserted-by":"crossref","first-page":"344223","DOI":"10.1016\/j.aca.2025.344223","article-title":"LC-MS\/MS-based determination of 25-hydroxyvitamin D in dried blood spots: crucial importance of combining a robust extraction with knowledge of the hematocrit","volume":"1367","author":"Heughebaert","year":"2025","journal-title":"Anal Chim Acta"},{"key":"R38-20260108","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2025-1002","article-title":"Clinical validation of a DBS-based LC-MS\/MS method for 25-hydroxyvitamin D: from lab sampling to home sampling","author":"Heughebaert","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"R39-20260108","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/jphp.12757","article-title":"Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling","volume":"69","author":"Boons","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"R42-20260108","doi-asserted-by":"crossref","first-page":"114623","DOI":"10.1016\/j.jpba.2022.114623","article-title":"Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratio","volume":"211","author":"Zimmermann","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"R43-20260108","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10549-014-2999-2","article-title":"Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen","volume":"146","author":"Jager","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R44-20260108","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/jcph.728","article-title":"The use of dried blood spots for pharmacokinetic monitoring of vemurafenib treatment in melanoma patients","volume":"56","author":"Nijenhuis","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"R45-20260108","doi-asserted-by":"crossref","first-page":"122985","DOI":"10.1016\/j.jchromb.2021.122985","article-title":"A new dried blood spot LC-MS\/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer","volume":"1185","author":"Poetto","year":"2021","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R46-20260108","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.3390\/cancers14194566","article-title":"Monitoring of dabrafenib and trametinib in serum and self-sampled capillary blood in patients with BRAFV600-mutant melanoma","volume":"14","author":"Isberner","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R47-20260108","article-title":"Jackknife resampling. Encyclopedia Environmetrics","author":"Friedl","year":"2001"},{"key":"R48-20260108","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000001330","article-title":"Development and clinical validation of a volumetric absorptive capillary microsampling method for quantification of mycophenolic acid and mycophenolic acid glucuronide in kidney transplant recipients","author":"Drevland","year":"2025","journal-title":"Ther Drug Monit"},{"key":"R49-20260108","doi-asserted-by":"crossref","first-page":"122140","DOI":"10.1016\/j.talanta.2021.122140","article-title":"Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS\/MS method","volume":"226","author":"Verougstraete","year":"2021","journal-title":"Talanta"},{"key":"R50-20260108","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000001387","article-title":"Towards clinical implementation of a volumetric absorptive microsampling-based method for dasatinib and imatinib therapeutic drug monitoring","author":"Verougstraete","year":"2025","journal-title":"Ther Drug Monit"},{"key":"R51-20260108","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12917-025-04748-2","article-title":"Volumetric absorptive microsampling to measure iohexol and creatinine concentrations for estimation of glomerular filtration rate in cats: aligning animal welfare with practical feasibility","volume":"21","author":"De Baets","year":"2025","journal-title":"BMC Vet Res"},{"key":"R52-20260108","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jpba.2018.05.011","article-title":"Determination of docetaxel in dried blood spots by LC-MS\/MS: method development, validation and clinical application","volume":"157","author":"Raymundo","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"R53-20260108","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/clinchem\/25.3.432","article-title":"Incorrect least-squares regression coefficients in method-comparison analysis","volume":"25","author":"Cornbleet","year":"1979","journal-title":"Clin Chem"},{"key":"R54-20260108","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/clinchem\/39.3.424","article-title":"Evaluation of regression procedures for methods comparison studies","volume":"39","author":"Linnet","year":"1993","journal-title":"Clin Chem"},{"key":"R55-20260108","first-page":"709","article-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I","volume":"21","author":"Passing","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"R56-20260108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-023-00866-7","article-title":"Clinical bridging studies and modeling approach for implementation of a patient centric sampling technique in padsevonil clinical development","volume":"26","author":"Kramer","year":"2023","journal-title":"AAPS J"},{"key":"R57-20260108","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.talanta.2014.10.040","article-title":"Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy","volume":"132","author":"Antunes","year":"2015","journal-title":"Talanta"},{"key":"R58-20260108","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clinbiochem.2018.02.020","article-title":"Analytical and clinical validation of a dried blood spot assay for the determination of paclitaxel using high-performance liquid chromatography-tandem mass spectrometry","volume":"54","author":"Andriguetti","year":"2018","journal-title":"Clin Biochem"},{"key":"R59-20260108","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.4155\/bio.15.101","article-title":"DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application","volume":"7","author":"Antunes","year":"2015","journal-title":"Bioanalysis"},{"key":"R60-20260108","doi-asserted-by":"crossref","first-page":"113102","DOI":"10.1016\/j.jpba.2020.113102","article-title":"Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS","volume":"182","author":"Londhe","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"R61-20260108","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/cclm-2023-0228","article-title":"Remote HbA(1c) testing via microsampling: fit for purpose?","volume":"62","author":"Verougstraete","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"R62-20260108","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/ajcn\/nqab146","article-title":"Volumetric absorptive microsampling (VAMS) as a reliable tool to assess thiamine status in dried blood microsamples: a comparative study","volume":"114","author":"Verstraete","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"R63-20260108","doi-asserted-by":"crossref","first-page":"116057","DOI":"10.1016\/j.trac.2020.116057","article-title":"Dried blood microsample-assisted determination of vitamins: recent developments and challenges","volume":"132","author":"Verstraete","year":"2020","journal-title":"TrAC Trends Anal Chem"},{"key":"R64-20260108","doi-asserted-by":"crossref","first-page":"121694","DOI":"10.1016\/j.talanta.2020.121694","article-title":"Quantitation of phosphatidylethanol in dried blood after volumetric absorptive microsampling","volume":"223","author":"Van Uytfanghe","year":"2021","journal-title":"Talanta"},{"key":"R65-20260108","doi-asserted-by":"crossref","first-page":"12175","DOI":"10.3390\/ijms241512175","article-title":"Phosphatidylethanol (PEth) in blood as a marker of unhealthy alcohol use: a systematic review with novel molecular insights","volume":"24","author":"Perilli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R66-20260108","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4155\/bio-2022-0242","article-title":"Method development for the quantification of lead levels in whole blood sampled on Mitra(\u00ae) with VAMS(\u00ae) tips by inductively coupled plasma-MS\/MS","volume":"15","author":"Breton","year":"2023","journal-title":"Bioanalysis"},{"key":"R67-20260108","doi-asserted-by":"crossref","first-page":"463724","DOI":"10.1016\/j.chroma.2022.463724","article-title":"Dried blood microsampling-assisted therapeutic drug monitoring of immunosuppressants: an overview","volume":"1689","author":"Deprez","year":"2023","journal-title":"J Chromatogr A"},{"key":"R68-20260108","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/FTD.0000000000000422","article-title":"Dried blood spot sampling for tacrolimus and mycophenolic acid in children: analytical and clinical validation","volume":"39","author":"Martial","year":"2017","journal-title":"Ther Drug Monit"},{"key":"R69-20260108","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinbiochem.2022.04.014","article-title":"Analytical and clinical validation of dried blood spot and volumetric absorptive microsampling for measurement of tacrolimus and creatinine after renal transplantation","volume":"105-106","author":"Mathew","year":"2022","journal-title":"Clin Biochem"},{"key":"R70-20260108","doi-asserted-by":"crossref","first-page":"114443","DOI":"10.1016\/j.jpba.2021.114443","article-title":"Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination","volume":"208","author":"Paniagua-Gonz\u00e1lez","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"R71-20260108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FTD.0000000000001024","article-title":"Fingerprick microsampling methods can replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid, and prednisolone concentrations in adult kidney transplant patients","volume":"45","author":"Scuderi","year":"2023","journal-title":"Ther Drug Monit"},{"key":"R72-20260108","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1515\/cclm-2019-1260","article-title":"Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring","volume":"58","author":"Veenhof","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"R73-20260108","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ibd\/izad103","article-title":"Clinical validation of a capillary blood home-based self-sampling technique for monitoring of infliximab, vedolizumab, and C-reactive protein concentrations in patients with inflammatory bowel disease","volume":"30","author":"Otten","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"R74-20260108","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/13524585221136448","article-title":"Fingerprick blood samples to measure serum natalizumab concentrations","volume":"29","author":"Toorop","year":"2023","journal-title":"Mult Scler"},{"key":"R75-20260108","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.4049\/jimmunol.2000767","article-title":"Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and nonhospitalized patients with COVID-19","volume":"205","author":"Vogelzang","year":"2020","journal-title":"J Immunol"},{"key":"R76-20260108","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13075-022-02809-7","article-title":"Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients-results from a randomized controlled trial","volume":"24","author":"Knitza","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"R77-20260108","doi-asserted-by":"crossref","first-page":"e003933","DOI":"10.1136\/rmdopen-2023-003933","article-title":"Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology","volume":"10","author":"Besten","year":"2024","journal-title":"RMD Open"},{"key":"R78-20260108","doi-asserted-by":"crossref","first-page":"115539","DOI":"10.1016\/j.jpba.2023.115539","article-title":"Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: from method development to clinical application","volume":"235","author":"da Silva","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"R79-20260108","article-title":"Does microsampling enhance preanalytical stability of uracil in dihydropyrimidine dehydrogenase (DPD) phenotyping?","author":"Vandenbroucke","year":"2025"},{"key":"R80-20260108","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/FTD.0000000000000269","article-title":"Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice: recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee","volume":"38","author":"Seger","year":"2016","journal-title":"Ther Drug Monit"},{"key":"R81-20260108","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/FTD.0000000000001261","article-title":"Toward analytical performance specifications for immunosuppressive drug quantification in transplantation: an opinion article","volume":"47","author":"Shipkova","year":"2025","journal-title":"Ther Drug Monit"},{"key":"R82-20260108","doi-asserted-by":"crossref","first-page":"340797","DOI":"10.1016\/j.aca.2023.340797","article-title":"Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer\u00ae qDBS device","volume":"1242","author":"Deprez","year":"2023","journal-title":"Anal Chim Acta"},{"key":"R83-20260108","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/toxins13050345","article-title":"Volumetric absorptive microsampling as an alternative tool for biomonitoring of multi-mycotoxin exposure in resource-limited areas","volume":"13","author":"Vidal","year":"2021","journal-title":"Toxins (Basel)"},{"key":"R84-20260108","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"R85-20260108","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4155\/bio-2018-0010","article-title":"Capillary blood microsampling to determine serum biopharmaceutical concentration: Mitra(\u00ae) microsampler vs dried blood spot","volume":"10","author":"Bloem","year":"2018","journal-title":"Bioanalysis"},{"key":"R86-20260108","doi-asserted-by":"crossref","first-page":"113491","DOI":"10.1016\/j.jpba.2020.113491","article-title":"Hematocrit prediction in volumetric absorptive microsamples","volume":"190","author":"Capiau","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"R87-20260108","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/ac303014b","article-title":"Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer","volume":"85","author":"Capiau","year":"2013","journal-title":"Anal Chem"},{"key":"R88-20260108","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0004563217726809","article-title":"Prediction of haematocrit in dried blood spots from the measurement of haemoglobin using commercially available sodium lauryl sulphate","volume":"55","author":"Richardson","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"R89-20260108","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1039\/D2AN01642G","article-title":"In-depth evaluation of automated non-contact reflectance-based hematocrit prediction of dried blood spots","volume":"147","author":"Boffel","year":"2022","journal-title":"Analyst"},{"key":"R90-20260108","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1021\/acs.analchem.6b01321","article-title":"A novel, nondestructive, dried blood spot-based hematocrit prediction method using noncontact diffuse reflectance spectroscopy","volume":"88","author":"Capiau","year":"2016","journal-title":"Anal Chem"},{"key":"R91-20260108","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cca.2021.10.002","article-title":"Near-infrared-based hematocrit prediction of dried blood spots: an in-depth evaluation","volume":"523","author":"Delahaye","year":"2021","journal-title":"Clin Chim Acta"},{"key":"R92-20260108","doi-asserted-by":"crossref","first-page":"111330","DOI":"10.1016\/j.microc.2024.111330","article-title":"Near-infrared-based hematocrit determination of dried blood samples collected by volumetric absorptive microsampling: an in-depth evaluation","volume":"205","author":"Heughebaert","year":"2024","journal-title":"Microchemical J"},{"key":"R93-20260108","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/FTD.0000000000000834","article-title":"Development and validation of hematocrit level measurement in dried blood spots using near-infrared spectroscopy","volume":"43","author":"van de Velde","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R94-20260108","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1111\/bcp.13371","article-title":"Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases","volume":"83","author":"Kneepkens","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"R95-20260108","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/jac\/dkaf041","article-title":"Clinical validation of an innovative dried whole-blood spot method to quantify simultaneously vancomycin and creatinine in adult patients","volume":"80","author":"Hassanzai","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"R96-20260108","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpba.2012.04.007","article-title":"Rapid and sensitive LC-MS\/MS method for the analysis of antibiotic linezolid on dried blood spot","volume":"67-68","author":"la Marca","year":"2012","journal-title":"J Pharm Biomed Anal"},{"key":"R97-20260108","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cpt.3272","article-title":"Evaluation of patient-centric sample collection technologies for pharmacokinetic assessment of large and small molecules","volume":"116","author":"Mandlekar","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"R98-20260108","doi-asserted-by":"crossref","first-page":"123075","DOI":"10.1016\/j.jchromb.2021.123075","article-title":"Measurement of 5- fluorouracil, capecitabine and its metabolite concentrations in blood using volumetric absorptive microsampling technology and LC-MS\/MS","volume":"1188","author":"Radovanovic","year":"2022","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R99-20260108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/FTD.0000000000000940","article-title":"Therapeutic drug monitoring of antibiotics: defining the therapeutic range","volume":"44","author":"Abdul-Aziz","year":"2022","journal-title":"Ther Drug Monit"},{"key":"R100-20260108","doi-asserted-by":"crossref","first-page":"116099","DOI":"10.1016\/j.jpba.2024.116099","article-title":"Simultaneous monitoring of seven antiepileptic drugs by dried blood spot and dried plasma spot sampling: method validation and clinical application of a LC-MS\/MS-based technique","volume":"243","author":"Cao","year":"2024","journal-title":"J Pharm Biomed Anal"},{"key":"R101-20260108","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/phar.2505","article-title":"A guide to therapeutic drug monitoring of \u03b2-lactam antibiotics","volume":"41","author":"Fratoni","year":"2021","journal-title":"Pharmacotherapy"},{"key":"R102-20260108","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17425255.2020.1724956","article-title":"Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects","volume":"16","author":"Johannessen Landmark","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R103-20260108","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/17512433.2023.2224562","article-title":"Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities","volume":"16","author":"M\u00fcller","year":"2023","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R104-20260108","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/jcm11113011","article-title":"Promising tools to facilitate the implementation of TDM of biologics in clinical practice","volume":"11","author":"Soenen","year":"2022","journal-title":"J Clin Med"},{"key":"R105-20260108","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1128\/AAC.00707-13","article-title":"Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole","volume":"57","author":"van der Elst","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R106-20260108","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s40262-022-01187-2","article-title":"Application of a volumetric absorptive microsampling (VAMS)-based method for the determination of paracetamol and four of its metabolites as a tool for pharmacokinetic studies in obese and Non-obese patients","volume":"61","author":"Boffel","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"R107-20260108","doi-asserted-by":"crossref","first-page":"c104","DOI":"10.1159\/000102997","article-title":"A practical method of measuring glomerular filtration rate by iohexol clearance using dried capillary blood spots","volume":"106","author":"Mafham","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"R108-20260108","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/ac8022839","article-title":"Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method","volume":"81","author":"Spooner","year":"2009","journal-title":"Anal Chem"},{"key":"R109-20260108","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s002280000179","article-title":"Use of saliva and capillary blood samples as substitutes for venous blood sampling in pharmacokinetic investigations of artemisinin","volume":"56","author":"Gordi","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"R110-20260108","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/cpdd.291","article-title":"Comparison of capillary and venous plasma drug concentrations after repeated administration of risperidone, paliperidone, quetiapine, olanzapine, or aripiprazole","volume":"5","author":"Remmerie","year":"2016","journal-title":"Clin Pharmacol Drug Dev"},{"key":"R111-20260108","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/AAC.02408-12","article-title":"Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers","volume":"57","author":"Instiaty","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R112-20260108","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3390\/molecules28166046","article-title":"Analytical and clinical validation of assays for volumetric absorptive microsampling (VAMS) of drugs in different blood matrices: a literature review","volume":"28","author":"Nugraha","year":"2023","journal-title":"Molecules"},{"key":"R113-20260108","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"R114-20260108","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/jcpt.13124","article-title":"Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia","volume":"45","author":"Lee","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"R115-20260108","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3390\/pharmaceutics14122547","article-title":"A volumetric absorptive microsampling UPLC-MS\/MS method for simultaneous quantification of tacrolimus, mycophenolic acid and creatinine in whole blood of renal transplant recipients","volume":"14","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"key":"R116-20260108","doi-asserted-by":"crossref","first-page":"e9372","DOI":"10.1002\/rcm.9372","article-title":"A rapid and sensitive ultra-performance liquid chromatography tandem mass spectrometry method for determination of anlotinib in plasma and dried blood spots: method development, validation, and clinical application","volume":"36","author":"Zhang","year":"2022","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R117-20260108","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/FTD.0000000000000502","article-title":"Dried blood spot analysis for therapeutic drug monitoring of antipsychotics: drawbacks of its clinical application","volume":"40","author":"Kloosterboer","year":"2018","journal-title":"Ther Drug Monit"},{"key":"R118-20260108","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/FTD.0000000000000703","article-title":"Clinical validation of a dried blood spot assay for 8 antihypertensive drugs and 4 active metabolites","volume":"42","author":"Peeters","year":"2020","journal-title":"Ther Drug Monit"},{"key":"R120-20260108","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/bcp.13755","article-title":"Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device","volume":"84","author":"Zwart","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"R121-20260108","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13318-023-00835-7","article-title":"Early at-home measurement of adalimumab concentrations to guide anti-TNF precision dosing: a pilot study","volume":"48","author":"de Klaver","year":"2023","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"R122-20260108","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/cts.12833","article-title":"Fasting status and circadian variation must be considered when performing AUC-based therapeutic drug monitoring of tacrolimus in renal transplant recipients","volume":"13","author":"Gustavsen","year":"2020","journal-title":"Clin Transl Sci"},{"key":"R123-20260108","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/FTD.0000000000000697","article-title":"Tacrolimus area under the concentration versus time curve monitoring, using home-based volumetric absorptive capillary microsampling","volume":"42","author":"Gustavsen","year":"2020","journal-title":"Ther Drug Monit"},{"key":"R124-20260108","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/FTD.0000000000001266","article-title":"Getting tacrolimus dosing right","volume":"47","author":"Marquet","year":"2025","journal-title":"Ther Drug Monit"},{"key":"R125-20260108","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/biomedicines11071962","article-title":"Biological fluid microsampling for therapeutic drug monitoring: a narrative review","volume":"11","author":"Cafaro","year":"2023","journal-title":"Biomedicines"},{"key":"R126-20260108","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/FTD.0000000000000884","article-title":"Microsampling devices for routine therapeutic drug monitoring-are we there yet?","volume":"43","author":"Morgan","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R130-20260108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13104-022-05958-9","article-title":"Comparison of self-sampling blood collection for N-glycosylation analysis","volume":"15","author":"Cvetko","year":"2022","journal-title":"BMC Res Notes"},{"key":"R131-20260108","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/ejh.13397","article-title":"Validity of plasma collection cards for ferritin assessment-a proof-of-concept study","volume":"104","author":"Koehler","year":"2020","journal-title":"Eur J Haematol"},{"key":"R132-20260108","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00216-022-04399-4","article-title":"Comprehensive lipidomic profiling by plasma separation cards","volume":"415","author":"Bishop","year":"2023","journal-title":"Anal Bioanal Chem"},{"key":"R133-20260108","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/jssc.202100700","article-title":"Dried plasma spot-based liquid chromatography-tandem mass spectrometry for the quantification of methotrexate in human plasma and its application in therapeutic drug monitoring","volume":"45","author":"Cao","year":"2022","journal-title":"J Sep Sci"},{"key":"R134-20260108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.steroids.2017.01.006","article-title":"Adhesive blood microsampling systems for steroid measurement via LC-MS\/MS in the rat","volume":"120","author":"Heussner","year":"2017","journal-title":"Steroids"},{"key":"R135-20260108","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1021\/acs.analchem.6b02199","article-title":"Procedures for analysis of dried plasma using microsampling devices to detect sulfur mustard-albumin adducts for verification of poisoning","volume":"88","author":"John","year":"2016","journal-title":"Anal Chem"},{"key":"R136-20260108","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.1021\/ac402735y","article-title":"Simple, miniaturized blood plasma extraction method","volume":"85","author":"Kim","year":"2013","journal-title":"Anal Chem"},{"key":"R137-20260108","doi-asserted-by":"crossref","first-page":"e4603","DOI":"10.1002\/jms.4603","article-title":"Therapeutic drug monitoring of valproic acid using a dried plasma spot sampling device","volume":"56","author":"Li","year":"2021","journal-title":"J Mass Spectrom"},{"key":"R138-20260108","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.4155\/bio.15.98","article-title":"Novel membrane devices and their potential utility in blood sample collection prior to analysis of dried plasma spots","volume":"7","author":"Sturm","year":"2015","journal-title":"Bioanalysis"},{"key":"R139-20260108","doi-asserted-by":"crossref","first-page":"e5554","DOI":"10.1002\/bmc.5554","article-title":"Exploring the potential of dried plasma collection cards for liquid chromatography coupled with tandem mass spectrometry quantitation of giredestrant in human plasma","volume":"37","author":"Tang","year":"2023","journal-title":"Biomed Chromatogr"},{"key":"R140-20260108","doi-asserted-by":"crossref","first-page":"13393","DOI":"10.1021\/acs.analchem.8b03175","article-title":"High-yield passive plasma filtration from human finger prick blood","volume":"90","author":"Hauser","year":"2018","journal-title":"Anal Chem"},{"key":"R141-20260108","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1021\/acs.analchem.9b00204","article-title":"An autonomous microfluidic device for generating volume-defined dried plasma spots","volume":"91","author":"Hauser","year":"2019","journal-title":"Anal Chem"},{"key":"R142-20260108","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/FTD.0000000000000825","article-title":"Simultaneous quantification of BCR-ABL and bruton tyrosine kinase inhibitors in dried plasma spots and its application to clinical sample analysis","volume":"43","author":"Mukai","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R143-20260108","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-3016.2010.01105.x","article-title":"The utility of neonatal dried blood spots for the assessment of neonatal vitamin D status","volume":"24","author":"Eyles","year":"2010","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R144-20260108","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1039\/C8AN01422A","article-title":"Development of a method for multiple vitamin D metabolite measurements by liquid chromatography coupled with tandem mass spectrometry in dried blood spots","volume":"144","author":"Rola","year":"2018","journal-title":"Analyst"},{"key":"R145-20260108","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0004563220937735","article-title":"Quantification of testosterone, androstenedione and 17-hydroxyprogesterone in whole blood collected using Mitra microsampling devices","volume":"57","author":"Marshall","year":"2020","journal-title":"Ann Clin Biochem"},{"key":"R146-20260108","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/FTD.0000000000000686","article-title":"Monitoring of adalimumab concentrations at home in patients with inflammatory bowel disease using dried blood samples","volume":"42","author":"Berends","year":"2020","journal-title":"Ther Drug Monit"},{"key":"R147-20260108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/cpt.3025","article-title":"Patient centric microsampling to support paxlovid clinical development: bridging and implementation","volume":"115","author":"Wan","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"R148-20260108","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1128\/AAC.01054-12","article-title":"Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis","volume":"56","author":"Vu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R149-20260108","doi-asserted-by":"crossref","first-page":"115108","DOI":"10.1016\/j.jpba.2022.115108","article-title":"Volumetric dried blood microsampling for monitoring imatinib mesylate therapy: method development and clinical application in patients with chronic myeloid leukemia","volume":"222","author":"Kr\u00fctzmann","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"R150-20260108","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cca.2021.03.003","article-title":"Can dried blood spots be used to accurately measure vitamin D metabolites?","volume":"518","author":"Binks","year":"2021","journal-title":"Clin Chim Acta"},{"key":"R151-20260108","doi-asserted-by":"crossref","first-page":"105472","DOI":"10.1016\/j.jsbmb.2019.105472","article-title":"Agreement between measurement of 25-hydroxyvitamin D(3) in dried blood spot samples and serum in a Chinese population in the Netherlands","volume":"195","author":"Man","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R152-20260108","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4155\/bio-2020-0136","article-title":"Validation and clinical application of a volumetric absorptive microsampling method for 14 psychiatric drugs","volume":"12","author":"Stern","year":"2020","journal-title":"Bioanalysis"},{"key":"R154-20260108","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1021\/acs.molpharmaceut.8b00785","article-title":"Predicting fraction unbound in human plasma from chemical structure: improved accuracy in the low value ranges","volume":"15","author":"Watanabe","year":"2018","journal-title":"Mol Pharm"},{"key":"R155-20260108","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/rcm.1777","article-title":"A novel liquid chromatography\/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery","volume":"19","author":"Yu","year":"2005","journal-title":"Rapid Commun Mass Spectrom"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:02:04Z","timestamp":1767848524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":145,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001393","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"2025-05-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}